請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/80909完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 李弘元(Hung-Yuan Li) | |
| dc.contributor.author | Szu-Chieh Chen | en |
| dc.contributor.author | 陳思潔 | zh_TW |
| dc.date.accessioned | 2022-11-24T03:21:30Z | - |
| dc.date.available | 2021-11-03 | |
| dc.date.available | 2022-11-24T03:21:30Z | - |
| dc.date.copyright | 2021-11-03 | |
| dc.date.issued | 2021 | |
| dc.date.submitted | 2021-09-26 | |
| dc.identifier.citation | 1. Hadden DR, McLaughlin C. Normal and abnormal maternal metabolism during pregnancy. Seminars in fetal neonatal medicine. 2009;14(2):66-71. 2. Herrera Martinez A, Palomares Ortega R, Bahamondes Opazo R, Moreno-Moreno P, Molina Puerta Mf, Galvez-Moreno MA. Hyperlipidemia during gestational diabetes and its relation with maternal and offspring complications. Nutricion hospitalaria. 2018;35(3):698-706. 3. Vejrazkova D, Vcelak J, Vankova M, et al. Steroids and insulin resistance in pregnancy. The Journal of steroid biochemistry and molecular biology. 2014;139:122-129. 4. Barrett HL DNM, McIntyre HD, Callaway LK. Normalizing metabolism in diabetic pregnancy: is it time to target lipids? Diabetes Care. 2014;37(5):1484-1493. 5. Trujillo ML, Spuch C, Carro E, Senaris R. Hyperphagia and central mechanisms for leptin resistance during pregnancy. Endocrinology. 2011;152(4):1355-1365. 6. Goldberg AS, Hegele RA. Severe hypertriglyceridemia in pregnancy. The Journal of clinical endocrinology and metabolism. 2012;97(8):2589-2596. 7. Wong B, Ooi TC, Keely E. Severe gestational hypertriglyceridemia: A practical approach for clinicians. Obstetric medicine. 2015;8(4):158-167. 8. Shen H, Liu X, Chen Y, He B, Cheng W. Associations of lipid levels during gestation with hypertensive disorders of pregnancy and gestational diabetes mellitus: a prospective longitudinal cohort study. BMJ open. 2016;6(12):e013509. 9. Wiznitzer A, Mayer A, Novack V, et al. Association of lipid levels during gestation with preeclampsia and gestational diabetes mellitus: a population-based study. American journal of obstetrics and gynecology. 2009;201(5):482 e481-488. 10. Gallo LA, Barrett HL, Dekker Nitert M. Review: Placental transport and metabolism of energy substrates in maternal obesity and diabetes. Placenta. 2017;54:59-67. 11. Vrijkotte TG, Krukziener N, Hutten BA, Vollebregt KC, van Eijsden M, Twickler MB. Maternal lipid profile during early pregnancy and pregnancy complications and outcomes: the ABCD study. The Journal of clinical endocrinology and metabolism. 2012;97(11):3917-3925. 12. Wang J, Moore D, Subramanian A, et al. Gestational dyslipidaemia and adverse birthweight outcomes: a systematic review and meta-analysis. Obes Rev. 2018;19(9):1256-1268. 13. Ryckman KK, Spracklen CN, Smith CJ, Robinson JG, Saftlas AF. Maternal lipid levels during pregnancy and gestational diabetes: a systematic review and meta-analysis. BJOG : an international journal of obstetrics and gynaecology. 2015;122(5):643-651. 14. Wu ET, Nien FJ, Kuo CH, et al. Diagnosis of more gestational diabetes lead to better pregnancy outcomes: Comparing the International Association of the Diabetes and Pregnancy Study Group criteria, and the Carpenter and Coustan criteria. J Diabetes Investig. 2016;7(1):121-126. 15. Kuo CH, Chen SC, Fang CT, et al. Screening gestational diabetes mellitus: The role of maternal age. PLoS One. 2017;12(3):e0173049. 16. Association AD. Standards of Medical Care in Diabetes. Diabetes Care. 2019;42(Suppl. 1):S13-S28. 17. Yee TW. Quantile regression via vector generalized additive models. Stat Med. 2004;23(14):2295-2315. 18. Zhu H, He D, Liang N, Lai A, Zeng J, Yu H. High serum triglyceride levels in the early first trimester of pregnancy are associated with gestational diabetes mellitus: A prospective cohort study. J Diabetes Investig. 2020;11(6):1635-1642. 19. Kelley DE. Skeletal muscle triglycerides: an aspect of regional adiposity and insulin resistance. Ann N Y Acad Sci. 2002 Jun;967:135-145. 20. Jin WY, Lin SL, Hou RL, et al. Associations between maternal lipid profile and pregnancy complications and perinatal outcomes: a population-based study from China. BMC pregnancy and childbirth. 2016;16:60. 21. Caughey AB SN, Washington AE, Escobar GJ. Maternal Ethnicity, Paternal Ethnicity, and Parental Ethnic Discordance: Predictors of Preeclampsia. Obstet Gynecol. 2005;106(1):156-161. 22. Chan TF, Tung YC, Wang SH, Lee CH, Lin CL, Lu PY. Trends in the incidence of pre-eclampsia and eclampsia in Taiwan between 1998 and 2010. Taiwanese journal of obstetrics gynecology. 2015;54(3):270-274. 23. Samsuddin S, Arumugam PA, Md Amin MS, et al. Maternal lipids are associated with newborn adiposity, independent of GDM status, obesity and insulin resistance: a prospective observational cohort study. BJOG : an international journal of obstetrics and gynaecology. 2020;127(4):490-499. 24. Elkins C, Friedrich D. Hypertriglyceridemia: A review of the evidence. Nurse Pract. 2018 Oct;43(10):22-29. 25. Rygiel K. Hypertriglyceridemia - Common Causes, Prevention and Treatment Strategies. Curr Cardiol Rev. 2018;14(1):67-76. 26. Subramanian S, Chait A. Hypertriglyceridemia secondary to obesity and diabetes. Biochim Biophys Acta. 2012;1821(5):819-825. 27. Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444(7121):881-887. 28. Tibshirani THR. Generalized additive models for medical research. Stat Methods Med Res. 1995 Sep;4(3):187-196. 29. Menger J, Koch S, Mouhieddine M, et al. Initial Postoperative Hemoglobin Values Are Independently Associated With One-Year Mortality in Patients Undergoing Double-Lung Transplantation Requiring Intraoperative Transfusion. J Cardiothorac Vasc Anesth. 2020. 30. Chen B, Trudeau MT, Maggino L, et al. Defining the Safety Profile for Performing Pancreatoduodenectomy in the Setting of Hyperbilirubinemia. Ann Surg Oncol. 2020;27(5):1595-1605. 31. Chang CH, Hu YH, Huang KH, et al. Higher Screening Aldosterone to Renin Ratio in Primary Aldosteronism Patients with Diabetes Mellitus. J Clin Med. 2018;7(10). | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/80909 | - |
| dc.description.abstract | 簡介:文獻中顯示懷孕期間的高三酸甘油脂血症和不良孕期結果相關。但是將血中三酸甘油降下來是否能改善孕期結果目前尚未可知,臨床上也需要切點作為執行的參考。因為目前對於孕期中三酸甘油脂切點並沒有共識,我們希望藉此研究找到第一孕期及第二孕期血中三酸甘油脂的切點數值。 方法:在這個前瞻性的研究中,收案對象為2013年11月至2018年04月在國立台灣大學附設醫院婦產科進行產檢並會接受口服葡萄糖耐量試驗以診斷是否有妊娠糖尿病的孕婦。若是孕婦有已知的自體免疫疾病、糖尿病、高血壓將不符合收案條件;若是懷孕雙胞胎以上或有在服用阿斯匹靈藥物的孕婦也在排除條件之中。我們會檢驗空腹狀態下第一孕期及第二孕期的三酸甘油脂;不良懷孕結果包含妊娠糖尿病或以胎齡校正後的體重過重兒。針對三酸甘油脂的數值及不良懷孕結果進行分析,使用的統計方法為廣義相加模型,希望找到孕期間高三酸甘油脂血症的定義。 結果:試驗收納了807對母親與胎兒,其中有161個不良孕期結果產生 (19.95%)。使用廣義相加模型做分析,我們發現第一孕期的三酸甘油脂轉折點為95 mg/dL及140 mg/dL;第二孕期為173 mg/dL及220 mg/dL,懷孕婦女孕期間血中的三酸甘油酯如果超過轉折點,其不良孕期結果的風險會上升 (第一孕期三酸甘油脂介於95-140 mg/dL,校正後的勝算比為2.16,95%信賴區間1.15-4.07,p值為0.017;第一孕期三酸甘油脂≥140 mg/dL,校正後的勝算比為2.56,95%信賴區間1.17-5.69,p值為0.019;第二孕期三酸甘油脂介於173-220 mg/dL,校正後的勝算比為1.24,95%信賴區間0.77-2.00,p值為0.385;第二孕期三酸甘油脂≥220 mg/dL,校正後的勝算比為1.70,95%信賴區間1.00-2.87,p值為0.049)。 結論:第一孕期空腹三酸甘油脂若超過95 mg/dL或140 mg/dL以及第二孕期空腹三酸甘油脂若超過220 mg/dL,孕婦妊娠糖尿病或產下以胎齡校正後的體重過重兒風險會大幅上升。 | zh_TW |
| dc.description.provenance | Made available in DSpace on 2022-11-24T03:21:30Z (GMT). No. of bitstreams: 1 U0001-1809202112254000.pdf: 1669375 bytes, checksum: 64eb384d3894bc90545106085335ad37 (MD5) Previous issue date: 2021 | en |
| dc.description.tableofcontents | 口試委員會審定書…………………………………………………………i 誌謝……………………………………………………………………………………ii 縮寫表……………………………………………………………………………iii 中文摘要…………………………………………………………………………iv 英文摘要…………………………………………………………………………vi Introduction………………………………………………………………1 Research Design and Methods………………………3 Result………………………………………………………………………………7 Conclusion…………………………………………………………………10 Reference……………………………………………………………………15 Table 1…………………………………………………………………………17 Table 2…………………………………………………………………………19 Table 3…………………………………………………………………………20 Table 4…………………………………………………………………………21 Table 5…………………………………………………………………………22 Figure 1………………………………………………………………………24 Figure 2………………………………………………………………………25 Figure 3………………………………………………………………………26 | |
| dc.language.iso | en | |
| dc.subject | 廣義相加模型 | zh_TW |
| dc.subject | 切點 | zh_TW |
| dc.subject | 孕期高三酸甘油脂血症 | zh_TW |
| dc.subject | 不良懷孕結果 | zh_TW |
| dc.subject | Gestational hypertriglyceridemia | en |
| dc.subject | Cutoffs | en |
| dc.subject | Generalized additive models | en |
| dc.subject | Adverse pregnancy outcomes | en |
| dc.title | 懷孕期間高三酸甘油脂血症與不良懷孕結果: 切點的探尋 | zh_TW |
| dc.title | Gestational Hypertriglyceridemia and Adverse Pregnancy Outcome: a Search for the Cutoffs | en |
| dc.date.schoolyear | 109-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 李建南(Hsin-Tsai Liu),方啟泰(Chih-Yang Tseng) | |
| dc.subject.keyword | 切點,孕期高三酸甘油脂血症,不良懷孕結果,廣義相加模型, | zh_TW |
| dc.subject.keyword | Cutoffs,Gestational hypertriglyceridemia,Adverse pregnancy outcomes,Generalized additive models, | en |
| dc.relation.page | 26 | |
| dc.identifier.doi | 10.6342/NTU202103240 | |
| dc.rights.note | 同意授權(限校園內公開) | |
| dc.date.accepted | 2021-09-26 | |
| dc.contributor.author-college | 醫學院 | zh_TW |
| dc.contributor.author-dept | 臨床醫學研究所 | zh_TW |
| 顯示於系所單位: | 臨床醫學研究所 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| U0001-1809202112254000.pdf 授權僅限NTU校內IP使用(校園外請利用VPN校外連線服務) | 1.63 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
